Iciq contract titled preclinical prevent program: toxicology and pharmacology
Ended Awarded Last action
- Contract number
- HHSN261201500024I
- Awardee
-
IIT Research Institute UEI DGBUFQYMKWB5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Task orders
- 5 $5,600,159 obligated
Award facts
- Opportunity
-
- N01CN4500945 Solicitation number
- Combined order value
-
- $5,600,159 Current, with exercised options
- $5,678,032 Potential, with all options
- Last date to order 100% complete
- IDV ceiling 29% used
- $19,000,000.00
- Maximum order
- $19,000,000.00
- Award type
- Multiple award
- Who can order
- Only the awarding agency
- NAICS code
- 541711 Research and Development in Biotechnology
- PSC
- R499 Support- Professional: Other
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 7 offers Negotiated Proposal / Quote
- Pricing
- Order Dependent (IDV only)
Award details come from SAM.gov/FPDS.
About this IDV
This federal indefinite delivery contract was awarded by the National Cancer Institute (NCI), a civilian agency within the Department of Health and Human Services, to the non-profit IIT Research Institute (IITRI). The $19 million PREVENT Toxicology and Pharmacology Testing (PREVENT TOX) IDIQ contract vehicle enables NCI to efficiently access IITRI's preclinical research capabilities on an as-needed basis to support the development of cancer prevention therapies.
Task orders issued under this IDIQ have tasked IITRI with conducting a variety of preclinical studies, including toxicology assessments of an LFA-9 small molecule therapy, aerosol development of the drug bexarotene, support for the clinical development of an endoxifen gel, and preclinical evaluation of a new lipid-based drug formulation. These task orders, valued between $321,110 and $2.1 million, provide firm-fixed price or cost-plus-fixed-fee type pricing for the specified research activities. The contracts do not have set-aside designations and the work is primarily performed at IITRI's facilities in Illinois.
Task orders
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Additional Work (new agreement, FAR part 6 applies) | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $0 |
Quick answers
Who was awarded contract HHSN261201500024I?
HHSN261201500024I was awarded to IIT Research Institute by National Cancer Institute (National Institutes of Health) on September 22, 2015.
How much is contract HHSN261201500024I worth?
Orders under HHSN261201500024I have obligated $5,600,159. Their combined potential value, with all options, is $5,678,032. HHSN261201500024I's own ceiling is $19,000,000. A single order can be worth up to $19,000,000.
How many orders have been placed under contract HHSN261201500024I?
5 orders have been placed under HHSN261201500024I, the latest on September 17, 2018.
Who can order from contract HHSN261201500024I?
HHSN261201500024I is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.
Is contract HHSN261201500024I part of a contract vehicle?
Yes. HHSN261201500024I is part of PREVENT Toxicology and Pharmacology Testing (PREVENT TOX).
Was contract HHSN261201500024I competed?
The extent of competition for HHSN261201500024I was full and open competition. The government received 7 offers.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV